We rank companies based on fund manager, research analyst and news sentiment
A stock icon

Agilent Technologies
A

$140.73
2.94%
 

About: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Employees: 17,700

0
Funds holding %
of 6,474 funds
0
Analysts bullish %
of 15 analysts
0
News positive %
of 10 articles

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 9 [Q3] → 18 (+9) [Q4]

48% more first-time investments, than exits

New positions opened: 161 | Existing positions closed: 109

28% more capital invested

Capital invested by funds: $27.8B [Q3] → $35.6B (+$7.81B) [Q4]

18% more call options, than puts

Call options by funds: $153M | Put options by funds: $129M

6% more funds holding

Funds holding: 893 [Q3] → 945 (+52) [Q4]

2.58% more ownership

Funds ownership: 84.8% [Q3] → 87.38% (+2.58%) [Q4]

10% less repeat investments, than reductions

Existing positions increased: 303 | Existing positions reduced: 338

Research analyst outlook

15 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$90
36%
downside
Avg. target
$137
3%
downside
High target
$165
17%
upside

15 analyst ratings

positive
40%
neutral
40%
negative
20%
Barclays
Luke Sergott
4%downside
$135
Underweight
Maintained
10 Apr 2024
Stifel
Daniel Arias
16%upside
$163
Buy
Upgraded
5 Apr 2024
Evercore ISI Group
Ross Muken
3%upside
$145
In-Line
Maintained
4 Apr 2024
Oppenheimer
Ian Zaffino
36%downside
$90
Outperform
Maintained
26 Mar 2024
Citigroup
Patrick Donnelly
3%upside
$145
Neutral
Maintained
28 Feb 2024

Financial journalist opinion

Based on 10 articles about A published over the past 30 days